Kallikreins and kallikrein-related peptidases

Articles in the same Issue

1. Editorial
2. Kallikreins and kallikrein-related peptidases
3. Guest Editorial
4. The 2^nd International Symposium on Kallikreins and Kallikrein-Related Peptidases (ISK 2007) and the Commemorative Gold Medal of the E.K. Frey–E. Werle Foundation of the Henning L. Voigt Family
5. Highlight: Kallikrein, kinins and kallikrein-related peptidases
6. Structures and specificity of the human kallikrein-related peptidases KLK 4, 5, 6, and 7
7. Development of peptides specifically modulating the activity of KLK2 and KLK3
8. Kallikreins and proteinase-mediated signaling: proteinase-activated receptors (PARs) and the pathophysiology of inflammatory diseases and cancer
9. Prostatic trypsin-like kallikrein-related peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PARs)
10. Human tissue kallikreins as promiscuous modulators of homeostatic skin barrier functions
11. A potential role for tissue kallikrein-related peptidases in human cervico-vaginal physiology
12. microRNAs: a new frontier in kallikrein research
13. Functions of KLK4 and MMP-20 in dental enamel formation
14. Genetic deficiency in tissue kallikrein activity in mouse and man: effect on arteries, heart and kidney
15. Development of diabetic cardiomyopathy and the kallikrein-kinin system – new insights from B1 and B2 receptor signaling
16. Doxorubicin cardiomyopathy-induced inflammation and apoptosis are attenuated by gene deletion of the kinin B1 receptor
17. Attenuation of left ventricular dysfunction by an ACE inhibitor after myocardial infarction in a kininogen-deficient rat model
18. Tissue kallikrein and kinin infusion promotes neovascularization in limb ischemia
19. Kallikreins as microRNA targets: an in silico and experimental-based analysis
20. Kallikreins are associated with secondary progressive multiple sclerosis and promote neurodegeneration
21. Immunofluorometric activity-based probe analysis of active KLK6 in biological fluids
22. Kallikrein 6 is a mediator of K-RAS-dependent migration of colon carcinoma cells
23. Gene expression changes associated with the anti-angiogenic activity of kallikrein-related peptidase 3 (KLK3) on human umbilical vein endothelial cells
24. An AKT activity threshold regulates androgen-dependent and androgen-independent PSA expression in prostate cancer cell lines
25. Quantitative RT-PCR analysis and immunohistochemical localization of the kallikrein-related peptidases 13 and 14 in lung